Your browser doesn't support javascript.
loading
Predictors of starting antimicrobial treatment in patients with nontuberculous mycobacterial lung disease in the Italian scenario: A SITA GIOVANI-IRENE promoted web-survey.
Lombardi, Andrea; Colaneri, Marta; Sambo, Margherita; Di Matteo, Angela; Sacchi, Paolo; Fabbiani, Massimiliano; Codecasa, Luigi; Aliberti, Stefano; Blasi, Francesco; Bandera, Alessandra; Bruno, Raffaele; Gori, Andrea.
Afiliação
  • Lombardi A; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Departement of Pathophysiology and Transplantation, University of Milano, Milano, Italy. Electronic address: andrea.lombardi@policlinico.mi.it.
  • Colaneri M; Infectious Diseases I Unit, IRCCS San Matteo, Pavia, Italy.
  • Sambo M; Infectious Diseases I Unit, IRCCS San Matteo, Pavia, Italy.
  • Di Matteo A; Infectious Diseases I Unit, IRCCS San Matteo, Pavia, Italy.
  • Sacchi P; Infectious Diseases I Unit, IRCCS San Matteo, Pavia, Italy.
  • Fabbiani M; Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Senese, Siena, Italy.
  • Codecasa L; TB Reference Centre, Villa Marelli Institute, Niguarda Hospital, Milan, Italy.
  • Aliberti S; Departement of Pathophysiology and Transplantation, University of Milano, Milano, Italy; Respiratory Unit and Cystic Fibrosis Adult Center, University of Milano, Milano, Italy.
  • Blasi F; Departement of Pathophysiology and Transplantation, University of Milano, Milano, Italy; Respiratory Unit and Cystic Fibrosis Adult Center, University of Milano, Milano, Italy.
  • Bandera A; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Departement of Pathophysiology and Transplantation, University of Milano, Milano, Italy; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
  • Bruno R; Infectious Diseases I Unit, IRCCS San Matteo, Pavia, Italy; Department of Medical, Surgical, Diagnostic and Paediatric Science, University of Pavia, Pavia, Italy.
  • Gori A; Infectious Diseases Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy; Departement of Pathophysiology and Transplantation, University of Milano, Milano, Italy; Centre for Multidisciplinary Research in Health Science (MACH), University of Milan, Milan, Italy.
Respir Med ; 179: 106341, 2021 04.
Article em En | MEDLINE | ID: mdl-33618080
ABSTRACT
The disease burden due to nontuberculous mycobacteria is growing worldwide, consequently to improved diagnostic abilities and an increase in the individuals at risk. Uncertainties exist about the right moment on which start treatment. We investigated the clinical features associated with starting an antimicrobial treatment in patients with nontuberculous mycobacterial lung disease among Italian physicians involved in the field. We found that in real life predictors of starting antimicrobial treatment are quite adherent to international guidelines, with some uncertainties regarding the implication of immunosuppressive drugs.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Pneumonia Bacteriana / Fidelidade a Diretrizes / Antibacterianos / Infecções por Mycobacterium não Tuberculosas Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Guias de Prática Clínica como Assunto / Pneumonia Bacteriana / Fidelidade a Diretrizes / Antibacterianos / Infecções por Mycobacterium não Tuberculosas Idioma: En Ano de publicação: 2021 Tipo de documento: Article